ES8304068A1 - Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro. - Google Patents

Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro.

Info

Publication number
ES8304068A1
ES8304068A1 ES511335A ES511335A ES8304068A1 ES 8304068 A1 ES8304068 A1 ES 8304068A1 ES 511335 A ES511335 A ES 511335A ES 511335 A ES511335 A ES 511335A ES 8304068 A1 ES8304068 A1 ES 8304068A1
Authority
ES
Spain
Prior art keywords
retro
procedure
cyclic
preparation
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511335A
Other languages
English (en)
Spanish (es)
Other versions
ES511335A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES511335A0 publication Critical patent/ES511335A0/es
Publication of ES8304068A1 publication Critical patent/ES8304068A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES511335A 1981-04-13 1982-04-08 Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro. Expired ES8304068A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/254,010 US4360516A (en) 1981-04-13 1981-04-13 Modified D-retro cyclic hexapeptide somatostatin analogs

Publications (2)

Publication Number Publication Date
ES511335A0 ES511335A0 (es) 1983-02-16
ES8304068A1 true ES8304068A1 (es) 1983-02-16

Family

ID=22962578

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511335A Expired ES8304068A1 (es) 1981-04-13 1982-04-08 Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro.

Country Status (9)

Country Link
US (1) US4360516A (enExample)
EP (1) EP0063308B1 (enExample)
JP (1) JPS57179142A (enExample)
AT (1) ATE14439T1 (enExample)
DE (1) DE3264861D1 (enExample)
DK (1) DK159382A (enExample)
ES (1) ES8304068A1 (enExample)
GR (1) GR75544B (enExample)
PT (1) PT74720B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427661A (en) * 1982-07-30 1984-01-24 Merck & Co., Inc. Fluorinated cyclic hexapeptide somatostatin analogs
CH655505B (enExample) * 1982-08-24 1986-04-30
DE3303345A1 (de) * 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Cyclische peptide mit somatostatin-wirkung
US4508711A (en) * 1983-04-18 1985-04-02 American Cyanamid Company Cyclic pentapeptide displaying somatostatin antagonism and method of treatment of mammals therewith
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4612366A (en) * 1985-06-17 1986-09-16 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
AU1194092A (en) * 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
IE920416A1 (en) * 1991-02-08 1992-08-12 Biomeasure Method of treating benign and malignant proliferative skin¹disease
US5811512A (en) * 1991-08-22 1998-09-22 The Trustees Of The University Of Pennsylvania Non-peptide peptidomimetics and related cyclic hexapeptides
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
PT980253E (pt) * 1997-05-13 2004-08-31 Conseils De Rec Appl Scient S Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
DE69816808T2 (de) * 1997-05-13 2004-04-15 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin agoniste zur reduzierung von körpergewicht
AU8019798A (en) * 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
CN101481405A (zh) 2001-06-08 2009-07-15 研究及应用科学协会股份有限公司 生长激素释放抑制因子-多巴胺嵌合类似物
EP1624884A4 (en) 2003-04-22 2009-08-05 Ipsen Pharma SOMATOSTATIN VECTORS
EP2719392B1 (en) 2008-06-12 2019-07-24 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
CA2726092A1 (en) 2008-06-12 2009-12-17 Syntaxin Limited Suppression of cancers
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
DK3007704T3 (da) 2013-06-13 2021-03-29 Antisense Therapeutics Ltd Kombinationsterapi til akromegali

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708136L (sv) * 1976-08-02 1978-02-03 Merck & Co Inc Cykliska hexapeptider
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
NZ195303A (en) * 1979-10-31 1984-10-19 Merck & Co Inc Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs

Also Published As

Publication number Publication date
EP0063308A1 (en) 1982-10-27
GR75544B (enExample) 1984-07-27
DE3264861D1 (en) 1985-08-29
EP0063308B1 (en) 1985-07-24
ES511335A0 (es) 1983-02-16
US4360516A (en) 1982-11-23
DK159382A (da) 1982-10-14
PT74720A (en) 1982-05-01
ATE14439T1 (de) 1985-08-15
JPH0360839B2 (enExample) 1991-09-17
PT74720B (en) 1985-01-08
JPS57179142A (en) 1982-11-04

Similar Documents

Publication Publication Date Title
ES8304068A1 (es) Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro.
NL7415786A (nl) Menginjectiespuit met twee kamers.
IT1053352B (it) Miscela per determinare la concentrazione di sostanze organiche e composti impiegati a tale scopo
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
IT1229190B (it) Aumentato recupero di petrolio mediante iniezione ciclica di prodotti chimici fluorurati.
ES2118708T3 (es) Composiciones de piperidina y su preparacion y utilizacion.
FR2322863A1 (fr) Amines cycliques substituees, utilisables notamment pour la preparation de pesticides
ES2076841T3 (es) Procedimiento para la preparacion de metilclorosilanos.
FR2534489B1 (fr) Reacteur utilisable, notamment dans les experiences chimiques
FR2524314B1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
ES551435A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
ES8202787A1 (es) Un procedimiento para la preparacion de un hexapeptido ci- clico
RO67158A (ro) Procedeu pentru separarea unor hidrocarburi aromatice din amestecuri care le contin
IT1079275B (it) Confezione contenente una composizione per il trattamento di tessuti e procedimento per tale trattamento
IT1143757B (it) Composti ciclici derivati dal tiopene,procedimento per la loro preparazione e loro impiego farmaceutico
ES8305702A1 (es) Un procedimiento para la preparacion de hexapeptido ciclico.
AT281786B (de) Verfahren zur Herstellung von sehr reinem (+)2,2'-(Äthylendiimino)-di-1-butanol-dihydrochlorid
DK139659B (da) Fremgangsmåde til fremstilling af gamma-globuliner til intravenos indgivelse.
FR1294M (fr) Procédé de fabrication de n-arylsulfonyl-n'-(2,5-endométhylene-1,2,5,6-tétrahydrobenzyl)-urées.
IT8321670V0 (it) Linguetta di bloccaggio per cinture di sicurezza di tipo con dispositivo di ritrazione.
ES450866A1 (es) Procedimiento para la preparacion de derivados de prostano.
MX145854A (es) Procedimiento mejorado para la separacion del 4,4'-diaminodifenilmetano de una mezcla que contiene el isomero 2,4'
FR1429976A (fr) Procédé de polymérisation de lactames contenant plus de six maillons
ES8303325A1 (es) "procedimiento para la preparacion de prostaglandinas".
NL7506346A (nl) Uit halfgeleiderelementen bestaand, faalveilig logisch systeem.